Opportunity

Simpler Grants.gov #HT942526MSRPIIRA

Army Grant Opportunity for Multiple Sclerosis Investigator-Initiated Research

Buyer

Dept. of the Army -- USAMRAA

Posted

May 05, 2026

Respond By

August 13, 2026

Identifier

HT942526MSRPIIRA

NAICS

541711

This opportunity from the Dept. of the Army supports innovative research projects focused on Multiple Sclerosis (MS) through the Investigator-Initiated Research Award (IIRA). - Government Buyer: - U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Congressionally Directed Medical Research Programs (CDMRP) - Products/Services Requested: - Highly rigorous, high-impact MS research projects - Projects must address at least one FY26 MSRP IIRA focus area - Clinical trials are excluded from eligible research phases - Open to both established and new investigators (including early-career faculty) - Funding Details: - Approximately $6,000,000 total funding - About six awards, each up to $1,000,000 - Maximum period of performance: 3 years per award - Unique/Notable Requirements: - Applicants must provide relevant preliminary and/or published data - Broad eligibility: domestic and foreign, for-profit and nonprofit organizations, public and private entities - No specific OEMs or vendors are mentioned, as this is a research grant opportunity rather than a product procurement.

Description

The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Multiple Sclerosis (MS) research, patient care, and/or quality of life. All applications must address at least one of the FY26 MSRP IIRA focus areas. Research projects may focus on any phase of research, excluding clinical trials. The funding mechanism includes two options: Established Investigator or New Investigator, with the New Investigator option supporting applicants early in their faculty appointments. The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $6.0 million to fund approximately six awards with total cost caps of $1.0 million per award and a maximum period of performance of 3 years.

View original listing